75 related articles for article (PubMed ID: 1477804)
1. Approaches for genetic purity testing of live recombinant viral vaccines using a human adenovirus:rabies model.
Lutze-Wallace C; Sapp T; Nadin-Davis SA; Wandeler A
Can J Vet Res; 1992 Oct; 56(4):360-4. PubMed ID: 1477804
[TBL] [Abstract][Full Text] [Related]
2. In vitro assessments of the genetic stability of a live recombinant human adenovirus vaccine against rabies.
Lutze-Wallace C; Sapp T; Sidhu M; Wandeler A
Can J Vet Res; 1995 Apr; 59(2):157-60. PubMed ID: 7648530
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a human adenovirus 5: rabies glycoprotein recombinant vaccine reisolated from orally vaccinated skunks.
Lutze-Wallace C; Wandeler A; Prevec L; Sidhu M; Sapp T; Armstrong J
Biologicals; 1995 Dec; 23(4):271-7. PubMed ID: 8825855
[TBL] [Abstract][Full Text] [Related]
4. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)].
Zhao ZP; Xia XZ; Hu RL; Xie ZJ; Yan F; Huang G; Yang ST
Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):335-9. PubMed ID: 17552245
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant replication-defective adenovirus based rabies vaccine].
Li WH; Zhang Y; Wang SH; Liu L; Yang F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB).
Knowles MK; Roberts D; Craig S; Sheen M; Nadin-Davis SA; Wandeler AI
Vaccine; 2009 May; 27(20):2662-8. PubMed ID: 19428876
[TBL] [Abstract][Full Text] [Related]
7. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
8. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
[TBL] [Abstract][Full Text] [Related]
9. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus].
Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ
Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263
[TBL] [Abstract][Full Text] [Related]
10. Analysis of recombinant adenoviruses using an integrated microfluidic chip-based system.
McCaman MT; Murakami P; Pungor E; Hahnenberger KM; Hancock WS
Anal Biochem; 2001 Apr; 291(2):262-8. PubMed ID: 11401300
[TBL] [Abstract][Full Text] [Related]
11. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.
Zhang X; Zhang Y; Li W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699
[TBL] [Abstract][Full Text] [Related]
12. [DNA cloning of Ad7 vaccine strain and sequence analysis of its Sma I H fragment].
Zhou J; Qu J; Shi C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):23-5. PubMed ID: 12515165
[TBL] [Abstract][Full Text] [Related]
13. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species.
Knowles MK; Nadin-Davis SA; Sheen M; Rosatte R; Mueller R; Beresford A
Vaccine; 2009 Nov; 27(47):6619-26. PubMed ID: 19698811
[TBL] [Abstract][Full Text] [Related]
14. Poxvirus-vectored vaccines for rabies--a review.
Weyer J; Rupprecht CE; Nel LH
Vaccine; 2009 Nov; 27(51):7198-201. PubMed ID: 19925953
[TBL] [Abstract][Full Text] [Related]
15. Reverse restriction fragment length polymorphism (RRFLP): A novel technique for genotyping infectious laryngotracheitis virus (ILTV) live attenuated vaccines.
Callison SA; Riblet SM; Rodríguez-Avila A; García M
J Virol Methods; 2009 Sep; 160(1-2):119-24. PubMed ID: 19433109
[TBL] [Abstract][Full Text] [Related]
16. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.
Xiang ZQ; Pasquini S; Ertl HC
J Immunol; 1999 Jun; 162(11):6716-23. PubMed ID: 10352290
[TBL] [Abstract][Full Text] [Related]
17. Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture.
Mousli M; Turki I; Kharmachi H; Saadi M; Dellagi K
J Virol Methods; 2007 Dec; 146(1-2):246-56. PubMed ID: 17845821
[TBL] [Abstract][Full Text] [Related]
18. Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine.
Tordo N; Bourhy H; Sather S; Ollo R
Virology; 1993 May; 194(1):59-69. PubMed ID: 8480429
[TBL] [Abstract][Full Text] [Related]
19. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
[TBL] [Abstract][Full Text] [Related]
20. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
